Peppy vs. Science.bio after its research-product closure notice

Disclosure: Peppy Care publishes this comparison of its own service. Public information checked October 22, 2026; no firsthand product testing. Seller statements are attributed, not independently certified.

The notice at science.bio states that the business permanently closed and discontinued research-product sales. It warns that claims of successor status, affiliation, or authorization to sell its products are unauthorized. The page reviewed does not give a closure date or explain the reason for the decision.

That is the basis for this comparison. It would be inaccurate to assign a specific shutdown date from discussion threads or infer a regulatory cause without additional primary evidence. It would also be misleading to compare Peppy with an imagined current Science.bio checkout, catalog price, or delivery promise.

An indexed product page, review, or social post can describe a past business state. Check its date and compare it with the original company’s current notice. A store using a familiar name or listing familiar compounds does not establish that it is the same legal business or an authorized continuation.

The Peptide Sciences closure comparison covers another original-site notice, but the facts are not interchangeable. Peptide Sciences’ stated March 2026 sales end should not be assigned to Science.bio. Each brand’s notice supports its own claims and leaves its own unanswered questions.

That depends on the underlying purpose. A research laboratory evaluating suppliers has different requirements from a person seeking help for a symptom or condition. This article does not rank replacement research vendors or convert archived products into a list of treatments to request.

For a health concern, start by describing the problem to a licensed clinician and considering established options. FDA’s online-pharmacy guidance emphasizes prescriptions, state pharmacy licensure, and pharmacist access when obtaining medicine online. A new seller’s claim to carry familiar research products does not provide those professional services.

Peppy’s shipping policy describes licensed-provider review of an intake and prescription transmission to a licensed compounding pharmacy when treatment is approved. Peppy is not presented here as Science.bio’s successor, and no relationship between the businesses is asserted. There is no promise that a compound from the former catalog can be prescribed.

Ask the clinician about the exact proposed medicine, the evidence for your situation, alternatives, costs, and follow-up. The FDA’s compounding guidance explains that compounded drugs are not FDA-approved. That remains part of an honest Peppy comparison. The practical change is from choosing a research product to seeking an accountable medical decision, including the possibility that a medicine is not needed or that an approved treatment is preferable.